RESEARCH-USE BIOSIMILAR ANTIBODY
Tarextumab
Monoclonal antibody · IgG2
Tarextumab (OMP-59R5) is a cross-reactive, fully human IgG2 antibody that selectively inhibits Notch2 and Notch3 signaling. Tarextumab demonstrates broad-spectrum antitumor efficacy in xenograft models of epithelial tumors. Tarextumab can be used for the study of pancreatic cancer.
TARGETNotch3
YMonoclonal antibody
TARGETNotch2
CATALOG NUMBERSC-BS-133
MOLECULAR WEIGHTApprox. 142.94 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tarextumab (OMP-59R5) is a cross-reactive, fully human IgG2 antibody that selectively inhibits Notch2 and Notch3 signaling. Tarextumab demonstrates broad-spectrum antitumor efficacy in xenograft models of epithelial tumors. Tarextumab can be used for the study of pancreatic cancer.
Tarextumab is a recombinant research-use antibody directed against Notch3 / Notch2.